Top Markets
#1 Fabric Protocol Fabric Protocol +29.17%
#2 The Black Bull The Black Bull +28.64%
#3 Ethena Staked ENA Ethena Staked ENA +28.15%
#4 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +27.44%
#5 Bitcoin Cash Bitcoin Cash +26.84%
#6 HashKey Platform Token HashKey Platform Token +26.07%
#7 GALA GALA +25.71%
#8 Zora Zora +24.31%
#9 Pieverse Pieverse +23.14%
#10 Prom Prom +23.08%
Coin of the day
Fabric Protocol Fabric Protocol
設定
言語
日本
通貨
USD
テーマ
Orexo AB Orexo AB

Orexo AB

ORX
株式のランク #24948
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
株価
$1.52
時価総額
$53.44M
変化（1日）
-2.85%
変化（1年）
-30.97%
国
SE
取引 Orexo AB (ORX)

カテゴリー

Healthcare
Orexo AB（ORX）の収益
Aug 2026 時点の収益 TTM: 0
Orexo AB の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Orexo AB の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK